RASAL1 and neoplasm: Antagonizing ZAP-70 inhibition by siRNA against Rasal1 increased the number of CD8+ tumor-infiltrating T-cells expressing granzyme B and interferon gamma (no ‘1') and enhanced tumor killing (51).